Cellex Cell Professionals is a full-service CDMO for cell therapy Cellex supports biopharma and academia with a full portfolio of services around cell and gene therapy for research, clinical and commercial use worldwide. Our company has experience in development of cGMP processes, GMP manufacturing of autologous and allogeneic cell therapy products using vectors and LNPs, quality control testing and release. In our state-of-the-art GMP facility cellular subsets can be separated and frozen but also genetically modified and analyzed. All processes are adapted to the customers' needs, based on profound experience with EU and FDA regulations. Cellex also stands for a successful tech transfer of processes from US to Europe. Our apheresis centers have all techniques for collection of different starting materials from healthy donors. Cellex runs its own highly diverse donor pool and offers leukopak, bone marrow or whole blood products customized for R&D, clinical or commercial purposes. IT and transport solutions complete the Cellex portfolio.
| Website | http://www.cellex.me |
| Revenue | $27.5 million |
| Employees | 234 (160 on RocketReach) |
| Founded | 2001 |
| Technologies |
HTML
,
Twitter
,
GoDaddy DNS
+3 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Cell Therapy Manufacturing, Cell And Gene Therapy, Full Service Cdmo, Cell Therapy Development, Contract Development Manufacturing, Biopharmaceutical Manufacturing, Pharmaceutical Manufacturing, Advanced Therapy Medicinal Products, Atmp Manufacturing |
| Competitors | Lonza, Thermo Fisher Scientific, Miltenyi Biotec, Merck Group, Cytiva, Panasonic North America, Bio-Rad Laboratories, Genomatix AG, STEMCELL Technologies, Sartorius CellGenix GmbH +50 more (view full list) |
Looking for a particular Cellex Cell Professionals employee's phone or email?
The Cellex Cell Professionals annual revenue was $27.5 million in 2026.
Anja Böhme is the CFO of Cellex Cell Professionals.
160 people are employed at Cellex Cell Professionals.